We are pleased to introduce Colin Carey, Spencer Lindsay, Jamie Morris, and Caitlin Panciocco, the runners who will represent TargetCancer Foundation in the 127th Boston Marathon®!
Each of our runners is taking on this challenge in tribute to a loved family member or friend who has received a rare cancer diagnosis. Their journeys and challenges are familiar to so many in this community, and we are incredibly grateful that they are willing to share them to bring more awareness to rare cancers, and to TargetCancer Foundation’s work. Their dedication and motivation are truly inspiring, and we encourage you to learn more about them by reading their personal stories on our Marathon campaign webpage.
This year’s team has set an ambitious goal to raise over $70,000, and to bring our all-time cumulative team fundraising total for the Boston Marathon past $450,000! Facing winter training in Boston, Chicago, and Washington DC, these incredible athletes are looking forward to your support over the next six months.
We can’t wait to see everything that this team is going to accomplish from now through April 17, 2023. Join us in congratulating Colin, Spencer, Jamie, and Caitlin on making the most competitive team in our program’s history, and wishing them good luck with their training and fundraising campaigns!
If you are a BAA qualified runner for the 2023 Marathon, you can run and support TargetCancer Foundation- contact us to learn more.
Team TargetCancer Foundation is proud to be an official Partner of John Hancock in the Marathon Non-Profit Program for the ninth straight year. The 127th running of the Boston Marathon will be held on Monday, April 17, 2023.
We once again want to thank the members of Team TargetCancer Foundation 2022, who raised over $45,000 in support of our rare cancer research and advocacy programs!
(L-R) Speros Varinos, Nelson Ambrogio, Krista Nordmark, and Shawn Price
~~~
Our sincere thanks to the John Hancock Non-Profit Marathon Program for providing TargetCancer Foundation with Boston Marathon entries.